Cart

Your cart is currently empty.

@dallasareapharm

You're Invited...🎆🎇 DAPA: December 2018 Meeting - COPD and Trelegy Ellipta - https://t.co/yrO2zmz6p3 https://t.co/YHLDri9ESI

h J R

@dallasareapharm

You're Invited...🎆🎇 DAPA: December 2018 Meeting - COPD and Trelegy Ellipta - https://t.co/fMqU4QvaoY https://t.co/sZuKxOUrpa

h J R

@dallasareapharm

You're Invited...🎆🎇 DAPA: December 2018 Meeting - COPD and Trelegy Ellipta - https://t.co/B4hH03skM1 https://t.co/NolVWbndeP

h J R

@dallasareapharm

You're Invited...🎆🎇 DAPA: December 2018 Meeting - COPD and Trelegy Ellipta - https://t.co/9fBOIjJkvM https://t.co/XVGVIGfKiz

h J R

@dallasareapharm

Let's BOWL & EAT! DAPA's Social Event is HERE! Register TODAY! - https://t.co/Dxn6PwOXLu

h J R

@dallasareapharm

Let's BOWL & EAT! DAPA's Social Event is HERE! Register TODAY! - https://t.co/VTia2I6Fll

h J R

@dallasareapharm

Let's BOWL & EAT! DAPA's Social Event is HERE! Register TODAY! - https://t.co/afYYmNFg0J

h J R

@dallasareapharm

RT @PharmacyPodcast: Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative c ht…

h J R

@dallasareapharm

What a successful DAPA November 2018 meeting at Del Frisco's Double Eagle Steakhouse (Plano) sponsored by AbbVie Ph… https://t.co/LpGuX8QVzw

h J R

@dallasareapharm

Let's BOWL & EAT! DAPA's Social Event is HERE! Register TODAY! - https://t.co/zg2Kd9Eo0I

h J R